Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) EBIT Margin (2016 - 2020)

Historic EBIT Margin for Glucotrack (GCTK) over the last 7 years, with Q2 2020 value amounting to 629896.91%.

  • Glucotrack's EBIT Margin fell 6290877100.0% to 629896.91% in Q2 2020 from the same period last year, while for Dec 2020 it was 137912.81%, marking a year-over-year decrease of 1405840200.0%. This contributed to the annual value of 1685.58% for FY2019, which is 167209900.0% up from last year.
  • Glucotrack's EBIT Margin amounted to 629896.91% in Q2 2020, which was down 6290877100.0% from 34774.61% recorded in Q1 2020.
  • In the past 5 years, Glucotrack's EBIT Margin registered a high of 9455.8% during Q4 2019, and its lowest value of 629896.91% during Q2 2020.
  • Over the past 5 years, Glucotrack's median EBIT Margin value was 1219.42% (recorded in 2016), while the average stood at 45883.65%.
  • Per our database at Business Quant, Glucotrack's EBIT Margin soared by 171538900bps in 2018 and then plummeted by 2000000000bps in 2020.
  • Quarter analysis of 5 years shows Glucotrack's EBIT Margin stood at 1020.51% in 2016, then soared by 490bps to 3984.61% in 2017, then plummeted by -430bps to 13130.81% in 2018, then soared by 172bps to 9455.8% in 2019, then crashed by -6761bps to 629896.91% in 2020.
  • Its EBIT Margin stands at 629896.91% for Q2 2020, versus 34774.61% for Q1 2020 and 9455.8% for Q4 2019.